Mayra L Guzman-Kaslow, president and CEO of GK Pharmaceuticals Contract Manufacturing Operations (GK CMO), the first biopharmaceutical company owned by minority woman in the US, highlights the obstacles she and her business partners faced on the way of setting up the company. She also explains why Puerto Rico has been the right place for establishing GK CMO, which is first and only pharmaceutical and biotechnology company on the island to have the technology and capacity to manufacture biologics, biosimilars, drug substances and solid drug products within the same facility.
As four women, born, raised and educated in Puerto Rico, we had to overcome many obstacles, so we want to be pioneers for a home-grown Puerto Rican pharma industry
